The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Anticancer Activity of Natural Compounds from Plant and Marine Environment
Open accessAbstract
This paper describes the substances of plant and marine origin that have anticancer properties. The chemical structure of the molecules of these substances, their properties, mechanisms of action, their structure–activity relationships, along with their anticancer properties and their potential as chemotherapeutic drugs are discussed in this paper. This paper presents natural substances from plants, animals, and their aquatic environments. These substances include the vinca alkaloids, mistletoe plant extracts, podophyllotoxin derivatives, taxanes, camptothecin, combretastatin, and others including geniposide, colchicine, artesunate, homoharringtonine, salvicine, ellipticine, roscovitine, maytanasin, tapsigargin, and bruceantin. Compounds (psammaplin, didemnin, dolastin, ecteinascidin, and halichondrin) isolated from the marine plants and animals such as microalgae, cyanobacteria, heterotrophic bacteria, invertebrates (e.g., sponges, tunicates, and soft corals) as well as certain other substances that have been tested on cells and experimental animals and used in human chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
Tabas, I., & Ron, D. (2011) · Nature Cell Biology · doi:10.1038/ncb0311-184 · Cited by 2,598
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Reference Module in Chemistry, Molecular Sciences and Chemical Engineering
(2014) · Choice Reviews Online · doi:10.5860/choice.51-6506 · Cited by 1,348
Nicolaou, K. C., Yang, Z., Liu, J. J., Ueno, H., Nantermet, P. G., Guy, R. K., Claiborne, C. F., Renaud, J., Couladouros, E. A., Paulvannan, K., et al. (1994) · Nature · doi:10.1038/367630a0 · Cited by 1,096
Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials
Newman, D. J., & Cragg, G. M. (2004) · Journal of Natural Products · doi:10.1021/np040031y · Cited by 759
De Azevedo, W. F., Leclerc, S., Meijer, L., Havlicek, L., Strnad, M., & Kim, S. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0518a.x · Cited by 729
Medicinal Plants: Their Use in Anticancer Treatment.
Greenwell, M., & Rahman, P. K. S. M. (2015) · International Journal of Pharmaceutical Sciences and Research · doi:10.13040/ijpsr.0975-8232.6(10).4103-12 · Cited by 696
First total synthesis of taxol. 1. Functionalization of the B ring
Holton, R. A., Somoza, C., Kim, H. B., Liang, F., Biediger, R. J., Boatman, P. D., Shindo, M., Smith, C. C., & Kim, S. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00083a066 · Cited by 635
Marine natural products as anticancer drugs
Simmons, T. L., Andrianasolo, E., McPhail, K., Flatt, P., & Gerwick, W. H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.333.4.2 · Cited by 597
Deniaud, A., Sharaf el dein, O., Maillier, E., Poncet, D., Kroemer, G., Lemaire, C., & Brenner, C. (2008) · Oncogene · doi:10.1038/sj.onc.1210638 · Cited by 586
Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylase
Darkin-Rattray, S. J., Gurnett, A. M., Myers, R. W., Dulski, P. M., Crumley, T. M., Allocco, J. J., Cannova, C., Meinke, P. T., Colletti, S. L., Bednarek, M. A., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13143 · Cited by 575
Targeting Microtubules by Natural Agents for Cancer Therapy
Mukhtar, E., Adhami, V. M., & Mukhtar, H. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0791 · Cited by 565
Highly efficient, practical approach to natural taxol
Denis, J. N., Greene, A. E., Guenard, D., Gueritte-Voegelein, F., Mangatal, L., & Potier, P. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00225a063 · Cited by 558
Bioactive natural products from marine cyanobacteria for drug discovery
Tan, L. T. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.01.012 · Cited by 534
From traditional Chinese medicine to rational cancer therapy
Efferth, T., Li, P. C. H., Konkimalla, V. S. B., & Kaina, B. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.07.001 · Cited by 528
First total synthesis of taxol. 2. Completion of the C and D rings
Holton, R. A., Kim, H. B., Somoza, C., Liang, F., Biediger, R. J., Boatman, P. D., Shindo, M., Smith, C. C., & Kim, S. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00083a067 · Cited by 524
A Review of Trabectedin (ET-743): A Unique Mechanism of Action
D'Incalci, M., & Galmarini, C. M. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0263 · Cited by 445
Total Synthesis of Baccatin III and Taxol
Danishefsky, S. J., Masters, J. J., Young, W. B., Link, J. T., Snyder, L. B., Magee, T. V., Jung, D. K., Isaacs, R. C. A., Bornmann, W. G., Alaimo, C. A., et al. (1996) · Journal of the American Chemical Society · doi:10.1021/ja952692a · Cited by 438
Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell lines
Liebmann, J., Cook, J., Lipschultz, C., Teague, D., Fisher, J., & Mitchell, J. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.488 · Cited by 428
Plant derived substances with anti-cancer activity: from folklore to practice
Fridlender, M., Kapulnik, Y., & Koltai, H. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00799 · Cited by 415
Total synthesis of halichondrin B and norhalichondrin B
Aicher, T. D., Buszek, K. R., Fang, F. G., Forsyth, C. J., Jung, S. H., Kishi, Y., Matelich, M. C., Scola, P. M., Spero, D. M., & Yoon, S. K. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00034a086 · Cited by 400
Distinct Autophagosomal-Lysosomal Fusion Mechanism Revealed by Thapsigargin-Induced Autophagy Arrest
Ganley, I. G., Wong, P.-M., Gammoh, N., & Jiang, X. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.024 · Cited by 382
Bai, R. L., Paull, K. D., Herald, C. L., Malspeis, L., Pettit, G. R., & Hamel, E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98491-7 · Cited by 379
Recent Developments in the Maytansinoid Antitumor Agents
Cassady, J. M., Chan, K. K., Floss, H. G., & Leistner, E. (2004) · CHEMICAL & PHARMACEUTICAL BULLETIN · doi:10.1248/cpb.52.1 · Cited by 342
Pettit, G. R., Singh, S. B., Niven, M. L., Hamel, E., & Schmidt, J. M. (1987) · Journal of Natural Products · doi:10.1021/np50049a016 · Cited by 328
Super Natural II—a database of natural products
Banerjee, P., Erehman, J., Gohlke, B.-O., Wilhelm, T., Preissner, R., & Dunkel, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku886 · Cited by 318
Indole Alkaloids from Catharanthus roseus: Bioproduction and Their Effect on Human Health
Almagro, L., Fernández-Pérez, F., & Pedreño, M. (2015) · Molecules · doi:10.3390/molecules20022973 · Cited by 291
Norhalichondrin A: an antitumor polyether macrolide from a marine sponge
Uemura, D., Takahashi, K., Yamamoto, T., Katayama, C., Tanaka, J., Okumura, Y., & Hirata, Y. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00302a042 · Cited by 289
MacCallum, D. E., Melville, J., Frame, S., Watt, K., Anderson, S., Gianella-Borradori, A., Lane, D. P., & Green, S. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0233 · Cited by 288
Rafiei, P., & Haddadi, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121881 · Cited by 284
Synthesis of Ecteinascidin ET-743 and Phthalascidin Pt-650 from Cyanosafracin B
Cuevas, C., Pérez, M., Martín, M. J., Chicharro, J. L., Fernández-Rivas, C., Flores, M., Francesch, A., Gallego, P., Zarzuelo, M., de la Calle, F., et al. (2000) · Organic Letters · doi:10.1021/ol0062502 · Cited by 282
Abou-Alfa, G. K., Letourneau, R., Harker, G., Modiano, M., Hurwitz, H., Tchekmedyian, N. S., Feit, K., Ackerman, J., De Jager, R. L., Eckhardt, S. G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0201 · Cited by 282
Docetaxel and Paclitaxel in the Treatment of Breast Cancer: A Review of Clinical Experience
Crown, J., O'Leary, M., & Ooi, W.-S. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_2-24 · Cited by 249
Erickson, H. K., Widdison, W. C., Mayo, M. F., Whiteman, K., Audette, C., Wilhelm, S. D., & Singh, R. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900315y · Cited by 246
Lopus, M., Oroudjev, E., Wilson, L., Wilhelm, S., Widdison, W., Chari, R., & Jordan, M. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0644 · Cited by 232
Denmeade, S. R., Mhaka, A. M., Rosen, D. M., Brennen, W. N., Dalrymple, S., Dach, I., Olesen, C., Gurel, B., DeMarzo, A. M., Wilding, G., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003886 · Cited by 220
Roscovitine in cancer and other diseases.
Cicenas, J., Kalyan, K. P., Sorokinas, A., Stankunas, E., Levy, J., Meskinyte, I., Stankevičius, V., Kaupinis, A., & Valius, M. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.03.61 · Cited by 219
Free Tubulin Modulates Mitochondrial Membrane Potential in Cancer Cells
Maldonado, E. N., Patnaik, J., Mullins, M. R., & Lemasters, J. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2429 · Cited by 218
Ecteinascidin 743: A Minor Groove Alkylator That Bends DNA toward the Major Groove
Zewail-Foote, M., & Hurley, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990241l · Cited by 214
Perspectives on Biologically Active Camptothecin Derivatives
Liu, Y.-Q., Li, W.-Q., Morris-Natschke, S. L., Qian, K., Yang, L., Zhu, G.-X., Wu, X.-B., Chen, A.-L., Zhang, S.-Y., Nan, X., et al. (2015) · Medicinal Research Reviews · doi:10.1002/med.21342 · Cited by 208
Role of plants in anticancer drug discovery
Khazir, J., Mir, B. A., Pilcher, L., & Riley, D. L. (2014) · Phytochemistry Letters · doi:10.1016/j.phytol.2013.11.010 · Cited by 189
U2504 Determines the Species Specificity of the A-Site Cleft Antibiotics:
Gürel, G., Blaha, G., Moore, P. B., & Steitz, T. A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.005 · Cited by 187
Wu, S.-Y., Wang, G.-F., Liu, Z.-Q., Rao, J.-J., Lü, L., Xu, W., Wu, S.-G., & Zhang, J.-J. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2008.17 · Cited by 175
Lai, H., & Singh, N. P. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.01.019 · Cited by 170
Nitroxides as Antioxidants and Anticancer Drugs
Lewandowski, M., & Gwoździński, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112490 · Cited by 167
Zhang, X., Rakesh, K. P., Shantharam, C. S., Manukumar, H. M., Asiri, A. M., Marwani, H. M., & Qin, H.-L. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.11.026 · Cited by 162
Du, J.-H., Zhang, H.-D., Ma, Z.-J., & Ji, K.-M. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1095-5 · Cited by 159
Zweifel, M., Jayson, G. C., Reed, N. S., Osborne, R., Hassan, B., Ledermann, J., Shreeves, G., Poupard, L., Lu, S.-P., Balkissoon, J., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq708 · Cited by 159
Moudi, M., Go, R., Yien, C. Y. S., et al. (2013) · PubMed · Cited by 159
Goto, K., Ohe, Y., Shibata, T., Seto, T., Takahashi, T., Nakagawa, K., Tanaka, H., Takeda, K., Nishio, M., Mori, K., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30104-8 · Cited by 155
Natural products as probes of cell biology: 20 years of didemnin research
Vera, M. D., & Joullié, M. M. (2002) · Medicinal Research Reviews · doi:10.1002/med.10003 · Cited by 154
Tassone, P., Gozzini, A., Goldmacher, V. S., Shammas, M. A., Whiteman, K. R., Carrasco, D. R., Li, C., Allam, C. K., Venuta, S., Anderson, K. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0142 · Cited by 152
Use of thapsigargin to study Ca2+ homeostasis in cardiac cells
Rogers, T. B., Inesi, G., Wade, R., & Lederer, W. J. (1995) · Bioscience Reports · doi:10.1007/bf01788366 · Cited by 147
Kienle, G. S., Glockmann, A., Schink, M., & Kiene, H. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-79 · Cited by 145
Recent Progress on C‐4‐Modified Podophyllotoxin Analogs as Potent Antitumor Agents
Liu, Y., Tian, J., Qian, K., et al. (2014) · Medicinal Research Reviews · doi:10.1002/med.21319 · Cited by 144
Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials.
Ribeiro, I. R., & Olliaro, P. (1998) · PubMed · Cited by 144
Topoisomerase II Binds to Ellipticine in the Absence or Presence of DNA.
Froelich-Ammon, S. J., Patchan, M. W., Osheroff, N., & Thompson, R. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.14998 · Cited by 137 · cited 3×
“Additionally, reactive oxygen species have been shown to play a key role in the salvicine-induced cellular response, including TOP2 inhibition, DNA damage, circumventing MDR and tumour cell adhesion inhibition [130].”
BackgroundShan, M., Yu, S., Yan, H., Guo, S., Xiao, W., Wang, Z., Li, Z., Ding, A., Wu, Q., & Li, S. (2017) · Molecules · doi:10.3390/molecules22101689 · Cited by 137
Zhou, H., Wang, W., Wu, G.-D., Lee, J. H., & Li, A. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.05.002 · Cited by 129
Habtemariam, S., & Lentini, G. (2018) · Biomedicines · doi:10.3390/biomedicines6020039 · Cited by 124
Kuo, P., Hsu, Y., Chang, C., & Lin, C. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.09.046 · Cited by 122
Zu-yi, Z. (2008) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20080206 · Cited by 118
Antitumor Activity of Bruceantin: An Old Drug with New Promise,
Cuendet, M., & Pezzuto, J. M. (2003) · Journal of Natural Products · doi:10.1021/np030304+ · Cited by 117
The taxanes: toxicity and quality of life considerations in advanced ovarian cancer
Guastalla, J. P., & Dieras, V. C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601496 · Cited by 116
Synthesis and Antitumor Activity of Novel Dolastatin 10 Analogs.
MIYAZAKI, K., Kobayashi, M., Natsume, T., Gondo, M., Mikami, T., SAKAKIBARA, K., & Tsukagoshi, S. (1995) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.43.1706 · Cited by 111
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
Michaelis, M., Kleinschmidt, M. C., Barth, S., Rothweiler, F., Geiler, J., Breitling, R., Mayer, B., Deubzer, H. E., Witt, O., Kreuter, J., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.013 · Cited by 110
Ljungman, M. E., & Paulsen, M. T. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12306-1 · Cited by 107
Edamatsu, H., Gau, C., Nemoto, T., Guo, L., & Tamanoi, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203625 · Cited by 107
Oxidative stress induced in rat liver by anticancer drugs doxorubicin, paclitaxel and docetaxel
Pieniążek, A., Czepas, J., Piasecka‐Zelga, J., Gwoździński, K., & Koceva‐Chyła, A. (2013) · Advances in Medical Sciences · doi:10.2478/v10039-012-0063-1 · Cited by 105
Ahn, M. Y., Jung, J. H., Na, Y. J., & Kim, H. S. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.098 · Cited by 102
Discovery of new anticancer agents from higher plants
Li, P. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/257 · Cited by 100
Maytansine binding to the vinblastine sites of tubulin
Bhattacharyya, B., & Wolff, J. (1977) · FEBS Letters · doi:10.1016/0014-5793(77)80075-6 · Cited by 100
Woodward, R. B., Iacobucci, G. A., & Hochstein, I. A. (1959) · Journal of the American Chemical Society · doi:10.1021/ja01525a085 · Cited by 99
Lin, Z., Wu, C., Chuang, Y.-H., & Chuang, W. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.07.002 · Cited by 96
Taxanes for the Treatment of Metastatic Breast Cancer
Gradishar, W. J. (2012) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s8205 · Cited by 94
Química e farmacologia de quimioterápicos antineoplásicos derivados de plantas
Brandão, H. N., David, J. P., Couto, R. D., Nascimento, J. A. P., & David, J. M. (2010) · Química Nova · doi:10.1590/s0100-40422010000600026 · Cited by 92
Discovery of new anticancer agents from higher plants
Kinghorn, A. D. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s257 · Cited by 92
Goodyear, S. M., & Sharma, M. C. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.09.002 · Cited by 91
Yeung, S. J., She, M., Yang, H., Pan, J., Sun, L., & Chaplin, D. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0027 · Cited by 90
Ellipticine cytotoxicity to cancer cell lines - a comparative study
Stiborová, M., Poljaková, J., Martínková, E., Bořek-Dohalská, L., Eckschlager, T., Kizek, R., & Frei, E. (2011) · Interdisciplinary Toxicology · doi:10.2478/v10102-011-0017-7 · Cited by 89
Current Status and Perspectives in the Development of Camptothecins
Zunino, F., Dallavalle, S., Laccabue, D., Beretta, G. L., Merlini, L., & Pratesi, G. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023392801 · Cited by 88
Kulke, M. H., Tempero, M. A., Niedzwiecki, D., Hollis, D. R., Kindler, H. L., Cusnir, M., Enzinger, P. C., Gorsch, S. M., Goldberg, R. M., & Mayer, R. J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1309 · Cited by 86
Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer
Konstat-Korzenny, E., Ascencio-Aragón, J. A., Niezen, S., & Vázquez-López, R. (2018) · Medical Sciences · doi:10.3390/medsci6010019 · Cited by 82
Shim, J. S., Lee, H., Shin, J., & Kwon, H. J. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.08.036 · Cited by 78
Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids
Lee, C., Huang, Y.-W., Yang, C.-H., & Huang, K. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150414120547 · Cited by 77
Colchicine Significantly Reduces Incident Cancer in Gout Male Patients: A 12-Year Cohort Study
Kuo, M., Chang, S., & Hsieh, M. (2015) · Medicine · doi:10.1097/md.0000000000001570 · Cited by 74
Kuo, Y.-C., Kuo, P., Hsu, Y., Cho, C.-Y., & Lin, C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.10.041 · Cited by 72
Pharmaceutical development of anticancer agents derived from marine sources
Nuijen, B., Bouma, M., Manada, C., Jimeno, J. M., Schellens, J. H. M., Bult, A., & Beijnen, J. H. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200011000-00003 · Cited by 71
Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients With Advanced Pancreatic Cancer
Lipton, A., Campbell‐Baird, C., Witters, L. M., Harvey, H. A., & Ali, S. M. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181cda097 · Cited by 68
Adams, D. J., Wahl, M., Flowers, J. L., Sen, B., Colvin, M., Dewhirst, M. W., Manikumar, G., & Wani, M. C. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0008-5 · Cited by 68
Mita, A. C., Hammond, L. A., Bonate, P. L., Weiss, G. R., McCreery, H., Syed, S. K., Garrison, M. A., Chu, Q. S.-C., Bono, J. S. D., Jones, C. B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0179 · Cited by 68
Mechanisms involved in Korean mistletoe lectin-induced apoptosis of cancer cells
Khil, L., Kim, W. I., Lyu, S., Park, W.-B., Yoon, J.-W., & Jun, H. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i20.2811 · Cited by 68
Lin, Z., Kuo, C., Wu, D., & Chuang, W. (2016) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2015.12.006 · Cited by 68
Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B
Potts, M. B., McMillan, E. A., Rosales, T. I., Kim, H. S., Ou, Y.-H., Toombs, J. E., Brekken, R. A., Minden, M. D., MacMillan, J. B., & White, M. A. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1797 · Cited by 67
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues
García, J. L., Franci, G., Pereira, R., Benedetti, R., Nebbioso, A., Rodríguez‐Barrios, F., Gronemeyer, H., Altucci, L., & de Lera, Á. R. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.026 · Cited by 66
Neuroprotective effects of geniposide on Alzheimer’s disease pathology
Liu, W., Li, G., Hölscher, C., & Li, L. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0005 · Cited by 63
König, M., von Hagens, C., Hoth, S., et al. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-2960-7 · Cited by 62
Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine
Erba, E., Bassano, L., Liberti, G., Muradore, I., Chiorino, G., Ubezio, P., Vignati, S., Codegoni, A. M., Desiderio, M. A., Faircloth, G. T., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600265 · Cited by 61
Takagi, K., Dexheimer, T. S., Redon, C. E., Sordet, O., Agama, K., Lavielle, G., Pierré, A., Bates, S. E., & Pommier, Y. G. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0441 · Cited by 59
The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
Tsao, C., Cutting, E., Martin, J. A., & Oh, W. K. (2014) · Therapeutic Advances in Urology · doi:10.1177/1756287214528557 · Cited by 59
Aplidine: A Paradigm of how to Handle the Activity and Toxicity of a Novel Marine Anticancer Poison
Tourneau, C. L., Raymond, É., & Faivre, S. J. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782360555 · Cited by 56
Ju, R.-J., Cheng, L., Peng, X., Wang, T., Li, C., Song, X., Liu, S., Chao, J., & Li, X. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1433187 · Cited by 53
Yarotskyy, V, & Elmslie, K. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707414 · Cited by 49 · cited 1×
“Olomoucine is a cyclin-dependent kinase inhibitor (CDK4) [141].”
BackgroundFifteen years of irinotecan therapy for pediatric sarcoma: where to next?
Wagner, L. M. (2015) · Clinical Sarcoma Research · doi:10.1186/s13569-015-0035-x · Cited by 47
Yang, X., Yao, J. J., Luo, Y., Han, Y., Wang, Z., & Du, L. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12234fp · Cited by 44
A review of topotecan in combination chemotherapy for advanced cervical cancer
Dunton, C. J. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1771 · Cited by 43
DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells
Poljaková, J., Frei, E., Elíes, J., Aimová, D., Eckschlager, T., Hraběta, J., & Stiborová, M. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.037 · Cited by 43
Philipp, S., Sosna, J., Plenge, J., Kalthoff, H., & Adam, D. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0103-0 · Cited by 43
Antitumor activity of TZT-1027 (Soblidotin).
Watanabe, J., Minami, M., & Kobayashi, M. (2006) · PubMed · Cited by 42
Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71
Zhao, F. L., WANG, H., KUNDA, P., Chen, X., LIU, Q.-L., & LIU, T. (2013) · Oncology Reports · doi:10.3892/or.2013.2574 · Cited by 37
König, M., von Hagens, C., Hoth, S., et al. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3023-9 · Cited by 37
Isah, T. (2015) · Journal of Pharmaceutical Research International · doi:10.9734/bjpr/2015/16293 · Cited by 36
Lee, M.-J., Hsu, J., & Wang, C. (1995) · PubMed · Cited by 32
Stefański, T., Mikstacka, R., Kurczab, R., Dutkiewicz, Z., Kucińska, M., Murias, M., Zielińska‐Przyjemska, M., Cichocki, M., Teubert, A., Kaczmarek, M., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.050 · Cited by 32
Preclinical Studies of Chemotherapy Using Histone Deacetylase Inhibitors in Endometrial Cancer
Takai, N., & Narahara, H. (2010) · Obstetrics and Gynecology International · doi:10.1155/2010/923824 · Cited by 31
Johnson, K. L., & Lawen, A. (1999) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1999.00821.x · Cited by 30
KOLODZIEJ, M., GOETZ, C., Fazio, P. D., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4105 · Cited by 29
Habib, S., Delourme, J., Dhalluin, X., Petyt, G., Tacelli, N., Scherpereel, A., Lafitte, J., & Cortot, A. B. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.01.015 · Cited by 26
Total synthesis of (+) artemisinin
Yadav, J. S., Babu, R. S., & Sabitha, G. (2003) · ARKIVOC · doi:10.3998/ark.5550190.0004.313 · Cited by 26
Canová, N. K., Kmonı́čková, E., Martínek, J., Zı́dek, Z., & Farghali, H. (2007) · Cell Biology and Toxicology · doi:10.1007/s10565-007-0185-6 · Cited by 24
Tiainen, L., Tanner, M., Lahdenperä, O., Vihinen, P., Jukkola‐Vuorinen, A., Karihtala, P., Paunu, N., Huttunen, T., & Kellokumpu‐Lehtinen, P. (2016) · Anticancer Research · doi:10.21873/anticanres.11241 · Cited by 24
Wu, C., Lin, Z., Kuoc, C.-H., & Chuang, W. (2015) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2015.01.008 · Cited by 23
Ebbinghaus, S., Hersh, E., Cunningham, C. C., O'Day, S. J., McDermott, D. F., Stephenson, J. R., Richards, D., Eckardt, J. R., Haider, O., & Hammond, L. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.7530 · Cited by 23
Advances in the Use of Taxanes in the Adjuvant Therapy of Breast Cancer
Nabholtz, J., Vannetzel, J.-M., Llory, J., & Bouffette, P. (2003) · Clinical Breast Cancer · doi:10.1016/s1526-8209(11)70624-3 · Cited by 22
Tabaczar, S., Czepas, J., Koceva‐Chyła, A., Kilańczyk, E., Piasecka‐Zelga, J., & Gwoździński, K. (2017) · PubMed · Cited by 20
Roscovitine inhibits ERK1/2 activation induced by angiotensin II in vascular smooth muscle cells
Li, A., Han, M., Zheng, B., & Wen, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.12.011 · Cited by 17
[Extraction of artemisinin and synthesis of its derivates artesunate and artemether].
Chekem, L., & Wierucki, S. (2006) · PubMed · Cited by 15
Evaluating the role of serine protease inhibition in the management of tumor micrometastases.
Putnam, J. B., Royston, D., Chambers, A. F., Dunbar, S., Lemmer, J. H., Norman, P., Travis, E. L., Vaporciyan, A. A., Yang, S. C., & Zacharski, L. R. (2003) · PubMed · Cited by 15
In Vitro Selection of DNA Aptamers that Binds Geniposide
Zhang, A., Chang, D., Zhang, Z., Li, F., Li, W., Wang, X., Li, Y., & Hua, Q. (2017) · Molecules · doi:10.3390/molecules22030383 · Cited by 13
Efficacy of paclitaxel in the treatment of Kaposi sarcoma.
Erçolak, V., Sahin, B., Günaldı, M., et al. (2015) · PubMed · Cited by 12
Hwang, J. J. (2004) · PubMed · Cited by 8
Novel therapeutics in breast cancer—Looking to the future
Vora, T. S., de Azambuja, E., Awada, A. H., & Piccart, M. J. (2009) · Update on Cancer Therapeutics · doi:10.1016/j.uct.2009.07.001 · Cited by 7
Sadahiro, S., Suzuki, T., Tanaka, A., Okada, K., Saito, G., & Kamijo, A. (2015) · Oncology · doi:10.1159/000369976 · Cited by 6
Cited by
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,834
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Bukowski, K., Kciuk, M., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093233 · Cited by 1,757
Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment
Garcia-Oliveira, P., Otero, P., Pereira, A. G., Chamorro, F., Carpena, M., Echave, J., Fraga-Corral, M., Simal-Gandara, J., & Prieto, M. A. (2021) · Pharmaceuticals · doi:10.3390/ph14020157 · Cited by 303
Cyanotherapeutics: An emerging field for future drug discovery
Tiwari, A. K., & Tiwari, B. S. (2020) · Applied Phycology · doi:10.1080/26388081.2020.1744480 · Cited by 49
Metadata
- Authors
- Lichota, A., & Gwozdzinski, K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-11-09
- Volume
- 19
- Issue
- 11
- Pages
- 3533
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2899961157
- Cited by
- 473
- References
- 136
- FWCI
- 22.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.